NETARSUDIL

NETARSUDIL was reported 1971 times

NETARSUDIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLEPHARECTOMY 1 0.5000
1 LACRIMAL PUNCTUM ENLARGED 1 0.5000
2 LYMPH NODE TRANSPLANT 1 0.5000
3 GLAUCOMA DRAINAGE DEVICE EXPOSURE 3 0.3750
4 BLEPHARITIS ALLERGIC 9 0.2903
5 CONJUNCTIVAL LACERATION 2 0.2000
6 CORNEA VERTICILLATA 60 0.1974
7 CONJUNCTIVAL PRIMARY ACQUIRED MELANOSIS 1 0.1250
8 CONJUNCTIVAL DEGENERATION 1 0.1250
9 EYELID ABRASION 2 0.1053
10 CORNEAL ENDOTHELIAL DISORDER 1 0.0909
11 CONJUNCTIVAL HYPERAEMIA 246 0.0689
12 CONJUNCTIVAL VASCULAR DISORDER 1 0.0556
13 CHOROIDAL HAEMORRHAGE 10 0.0518
14 CORNEAL CYST 5 0.0515
15 CONJUNCTIVAL PIGMENTATION 2 0.0500
16 CONJUNCTIVAL CYST 3 0.0469
17 UVEAL PROLAPSE 1 0.0455
18 IRIS DISCOLOURATION 2 0.0435
19 CORNEAL OEDEMA 95 0.0424
20 NONINFECTIVE CHORIORETINITIS 1 0.0333
21 MACULAR DYSTROPHY CONGENITAL 1 0.0323
22 CORNEAL BLEEDING 3 0.0312
23 ORBITAL HAEMATOMA 1 0.0294
24 CORNEAL DEGENERATION 7 0.0289
25 CARDIAC SEPTAL DEFECT REPAIR 1 0.0286
26 REFRACTION DISORDER 8 0.0275
27 CONJUNCTIVAL FILTERING BLEB LEAK 1 0.0263
28 HYPOTONY MACULOPATHY 1 0.0244
29 DACRYOSTENOSIS ACQUIRED 30 0.0232
30 FEMALE SEX HORMONE LEVEL ABNORMAL 1 0.0227
31 OCULAR PROCEDURAL COMPLICATION 4 0.0206
32 GIANT PAPILLARY CONJUNCTIVITIS 1 0.0200
33 IRIS HAEMORRHAGE 1 0.0196
34 BIRDSHOT CHORIORETINOPATHY 1 0.0182
35 ATOPY 5 0.0180
36 CORNEAL PIGMENTATION 1 0.0175
37 CORNEAL NEOVASCULARISATION 4 0.0162
38 ARCUS LIPOIDES 1 0.0159
39 NAIL DEFORMATION 1 0.0149
40 EYE ALLERGY 23 0.0148
41 CONJUNCTIVAL IRRITATION 2 0.0148
42 HYPOTONY OF EYE 6 0.0143
43 OCULAR SURFACE DISEASE 4 0.0142
44 ARTHROPOD INFESTATION 1 0.0135
45 CONJUNCTIVITIS ALLERGIC 20 0.0135
46 CONJUNCTIVAL SCAR 2 0.0132
47 CONJUNCTIVAL DISORDER 5 0.0131
48 PERIORBITAL DERMATITIS 1 0.0128
49 CHOROIDAL EFFUSION 10 0.0125
50 CORNEAL EPITHELIAL MICROCYSTS 2 0.0120
51 EYELID BLEEDING 2 0.0116
52 TRABECULECTOMY 1 0.0109
53 CHOROIDAL DETACHMENT 6 0.0108
54 CORNEAL DEPOSITS 8 0.0108
55 CILIARY HYPERAEMIA 1 0.0105
56 GLARE 5 0.0097
57 INSTILLATION SITE ERYTHEMA 5 0.0095
58 ATROPHIC GLOSSITIS 1 0.0092
59 VOGT-KOYANAGI-HARADA DISEASE 2 0.0091
60 KERATORHEXIS 1 0.0088
61 PERIORBITAL INFLAMMATION 2 0.0087
62 EYELASH THICKENING 1 0.0083
63 CATARACT SUBCAPSULAR 5 0.0082
64 EXPOSURE TO RADIATION 1 0.0079
65 HYPHAEMA 4 0.0077
66 INTRAOCULAR PRESSURE DECREASED 4 0.0076
67 CONJUNCTIVAL HAEMORRHAGE 29 0.0076
68 CORNEAL DEFECT 1 0.0076
69 INSTILLATION SITE DISCOMFORT 1 0.0075
70 INTRAOCULAR PRESSURE INCREASED 95 0.0074
71 CORNEAL OPACITY 10 0.0073
72 CONJUNCTIVAL ULCER 1 0.0072
73 OCULAR STROKE 1 0.0072
74 ADMINISTRATION SITE IRRITATION 1 0.0071
75 OCULAR LYMPHOMA 1 0.0071
76 NON-24-HOUR SLEEP-WAKE DISORDER 1 0.0071
77 INSTILLATION SITE FOREIGN BODY SENSATION 1 0.0069
78 PUNCTATE KERATITIS 6 0.0065
79 ABSCESS SOFT TISSUE 1 0.0065
80 INSTILLATION SITE PAIN 16 0.0065
81 EYELID PAIN 13 0.0064
82 OPEN GLOBE INJURY 1 0.0061
83 CORNEAL SCAR 3 0.0060
84 ECTROPION 2 0.0059
85 DIABETIC RETINAL OEDEMA 3 0.0059
86 INSTILLATION SITE SWELLING 1 0.0057
87 INTRAOCULAR PRESSURE TEST ABNORMAL 4 0.0057
88 EYELASH CHANGES 1 0.0056
89 EYE INFECTION FUNGAL 2 0.0052
90 CORNEAL TRANSPLANT 4 0.0051
91 INTRAOCULAR PRESSURE FLUCTUATION 1 0.0051
92 REACTION TO PRESERVATIVES 4 0.0049
93 BLEPHARITIS 19 0.0047
94 CHOLELITHOTOMY 1 0.0046
95 SUPERFICIAL INJURY OF EYE 5 0.0046
96 RIGHT-TO-LEFT CARDIAC SHUNT 1 0.0045
97 MEIBOMIAN GLAND DYSFUNCTION 2 0.0044
98 CYSTOID MACULAR OEDEMA 8 0.0042
99 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 1 0.0042
100 VITREOUS DISORDER 2 0.0041
101 TYPE V HYPERLIPIDAEMIA 2 0.0041
102 INCISION SITE DISCHARGE 1 0.0040
103 CORNEAL THINNING 1 0.0039
104 BACTERIAL ENDOPHTHALMITIS 1 0.0038
105 FOREIGN BODY SENSATION IN EYES 23 0.0036
106 OCULAR HYPERTENSION 7 0.0036
107 PRODUCT CLOSURE ISSUE 2 0.0036
108 SUDDEN VISUAL LOSS 1 0.0036
109 RETINAL OPERATION 1 0.0036
110 EYELID IRRITATION 9 0.0036
111 PERIORBITAL PAIN 3 0.0035
112 AGONAL RESPIRATION 1 0.0035
113 ANDROGENETIC ALOPECIA 1 0.0035
114 EYELID THICKENING 1 0.0035
115 ERYTHEMA OF EYELID 19 0.0035
116 CORNEAL EPITHELIUM DEFECT 2 0.0034
117 OCULAR HYPERAEMIA 162 0.0034
118 PRODUCT DELIVERY MECHANISM ISSUE 18 0.0033
119 VISUAL ACUITY REDUCED TRANSIENTLY 1 0.0032
120 INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS 1 0.0032
121 CORNEAL DISORDER 7 0.0032
122 EYELID MARGIN CRUSTING 9 0.0031
123 LACRIMATION INCREASED 94 0.0031
124 CATARACT NUCLEAR 2 0.0030
125 IRITIS 9 0.0030
126 PRODUCT CLOSURE REMOVAL DIFFICULT 3 0.0029
127 VIRAL DIARRHOEA 1 0.0029
128 TACHYPHYLAXIS 1 0.0029
129 PATIENT ELOPEMENT 1 0.0027
130 OBSESSIVE-COMPULSIVE SYMPTOM 1 0.0027
131 VISUAL ACUITY REDUCED 89 0.0027
132 NEUROSARCOIDOSIS 1 0.0027
133 HALO VISION 3 0.0027
134 INSTILLATION SITE PRURITUS 1 0.0027
135 EYE PAIN 149 0.0026
136 CAUDA EQUINA SYNDROME 2 0.0026
137 INTRACRANIAL TUMOUR HAEMORRHAGE 1 0.0026
138 EYELIDS PRURITUS 8 0.0026
139 EYELID EXFOLIATION 2 0.0025
140 PHYSICAL PRODUCT LABEL ISSUE 3 0.0025
141 BLOOD URIC ACID ABNORMAL 1 0.0025
142 HYPOPYON 2 0.0024
143 DYSCHROMATOPSIA 2 0.0024
144 RETINAL PIGMENT EPITHELIOPATHY 1 0.0023
145 ENDOCRINE OPHTHALMOPATHY 2 0.0023
146 HERPES OPHTHALMIC 3 0.0023
147 PRODUCT WITH QUALITY ISSUE ADMINISTERED 1 0.0022
148 CORNEAL ABRASION 3 0.0022
149 BODY MASS INDEX DECREASED 1 0.0022
150 EYE IRRITATION 123 0.0021
151 BLOOD PHOSPHORUS ABNORMAL 1 0.0021
152 MEAN CELL VOLUME ABNORMAL 1 0.0021
153 KERATIC PRECIPITATES 1 0.0021
154 MYOPIA 5 0.0021
155 EYE PRURITUS 70 0.0021
156 BLOOD BICARBONATE INCREASED 1 0.0021
157 PATIENT DISSATISFACTION WITH TREATMENT 4 0.0021
158 SWELLING OF EYELID 13 0.0021
159 EYELID RASH 2 0.0020
160 EYE DISCHARGE 21 0.0020
161 BLEPHARAL PIGMENTATION 1 0.0020
162 KERATITIS 6 0.0020
163 CONJUNCTIVAL OEDEMA 2 0.0019
164 RETINAL VASCULAR THROMBOSIS 1 0.0019
165 KERATOPATHY 3 0.0019
166 OCULAR DISCOMFORT 21 0.0019
167 CORNEAL EROSION 1 0.0019
168 DENTAL IMPLANTATION 3 0.0018
169 EYE INFECTION BACTERIAL 1 0.0018
170 OPHTHALMIC HERPES SIMPLEX 1 0.0017
171 PRODUCT CONTAINER SEAL ISSUE 3 0.0017
172 SUTURE INSERTION 1 0.0017
173 HYPOAESTHESIA EYE 1 0.0017
174 INSTILLATION SITE IRRITATION 2 0.0017
175 EYELID SKIN DRYNESS 2 0.0016
176 CORTISOL INCREASED 1 0.0016
177 CHALAZION 1 0.0016
178 NEUROPATHIC ARTHROPATHY 1 0.0015
179 RETINAL DISORDER 4 0.0015
180 PRODUCT PACKAGING DIFFICULT TO OPEN 4 0.0015
181 HALLUCINATION, TACTILE 1 0.0015
182 POST PROCEDURAL SEPSIS 1 0.0015
183 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
184 PHOTOPHOBIA 28 0.0015
185 UVEITIS 20 0.0015
186 MONOCYTE PERCENTAGE INCREASED 1 0.0014
187 PRODUCT DESIGN ISSUE 1 0.0014
188 PRODUCT CONTAINER ISSUE 12 0.0014
189 EYE INFLAMMATION 13 0.0014
190 RETINAL VASCULAR OCCLUSION 1 0.0013
191 PRODUCT PACKAGE ASSOCIATED INJURY 3 0.0013
192 BASOPHIL COUNT INCREASED 1 0.0013
193 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
194 PRODUCT DEPOSIT 2 0.0013
195 PRODUCT DROPPER ISSUE 1 0.0013
196 DEVICE DAMAGE 1 0.0013
197 FEAR OF FALLING 1 0.0012
198 EYE OEDEMA 3 0.0012
199 OCULAR VASCULAR DISORDER 1 0.0012
200 VISION BLURRED 165 0.0012
201 SEROUS RETINAL DETACHMENT 1 0.0012
202 RETINAL ARTERY OCCLUSION 3 0.0012
203 BLOOD CHLORIDE DECREASED 3 0.0012
204 TREATMENT DELAYED 2 0.0012
205 GASTROINTESTINAL NEOPLASM 1 0.0012
206 ABSCESS DRAINAGE 1 0.0012
207 ESSENTIAL HYPERTENSION 2 0.0011
208 BONE CONTUSION 1 0.0011
209 GLAUCOMA 21 0.0011
210 PRODUCT SHAPE ISSUE 1 0.0011
211 RETINAL OEDEMA 2 0.0010
212 FOREIGN BODY IN EYE 1 0.0010
213 RED BLOOD CELL ABNORMALITY 1 0.0010
214 HYPERAEMIA 2 0.0010
215 CARDIAC ANEURYSM 1 0.0010
216 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
217 BUTTERFLY RASH 1 0.0010
218 EYE COLOUR CHANGE 1 0.0010
219 IRIDOCYCLITIS 3 0.0009
220 ALLERGY TO ANIMAL 1 0.0009
221 NEUROMYOPATHY 1 0.0009
222 ABNORMAL SENSATION IN EYE 4 0.0009
223 EXOPHTHALMOS 2 0.0009
224 HORDEOLUM 4 0.0009
225 UTERINE PROLAPSE 1 0.0009
226 KIDNEY ENLARGEMENT 1 0.0009
227 INSTILLATION SITE REACTION 1 0.0009
228 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
229 DEMENTIA WITH LEWY BODIES 1 0.0009
230 PERIORBITAL SWELLING 5 0.0009
231 BLOOD LOSS ANAEMIA 2 0.0009
232 ADMINISTRATION SITE PAIN 1 0.0009
233 SURGICAL FAILURE 1 0.0009
234 MACROCYTOSIS 1 0.0009
235 OPTIC NERVE INJURY 1 0.0009
236 DRY EYE 43 0.0009
237 INCISION SITE PAIN 1 0.0009
238 BLEEDING TIME PROLONGED 1 0.0008
239 RECTAL PROLAPSE 1 0.0008
240 EYE HAEMORRHAGE 11 0.0008
241 HAEMATOCRIT ABNORMAL 1 0.0008
242 CONJUNCTIVITIS 15 0.0008
243 MALIGNANT MELANOMA IN SITU 1 0.0008
244 HYPERAESTHESIA TEETH 1 0.0008
245 SEROMA 1 0.0008
246 CAROTID ARTERY DISEASE 1 0.0008
247 EYELID OEDEMA 9 0.0008
248 BILIARY OBSTRUCTION 1 0.0008
249 APPLICATION SITE PARAESTHESIA 1 0.0008
250 ACROCHORDON 1 0.0008
251 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
252 CYSTITIS NONINFECTIVE 1 0.0007
253 PRODUCT SIZE ISSUE 4 0.0007
254 POSTPARTUM HAEMORRHAGE 1 0.0007
255 CALCULUS BLADDER 1 0.0007
256 INTESTINAL MASS 1 0.0007
257 ULCERATIVE KERATITIS 2 0.0007
258 ASTHENOPIA 4 0.0007
259 EYE SWELLING 27 0.0007
260 VITREOUS HAEMORRHAGE 2 0.0007
261 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
262 BLINDNESS UNILATERAL 10 0.0007
263 PHARYNGEAL DISORDER 2 0.0007
264 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
265 EYELID PTOSIS 7 0.0007
266 SLEEP PARALYSIS 1 0.0007
267 DARK CIRCLES UNDER EYES 1 0.0007
268 APRAXIA 1 0.0007
269 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
270 ASTIGMATISM 1 0.0007
271 EYE OPERATION 3 0.0007
272 SCLERITIS 1 0.0006
273 EYE INFECTION 7 0.0006
274 SHOULDER FRACTURE 1 0.0006
275 OXYGEN THERAPY 1 0.0006
276 BLOOD CALCIUM ABNORMAL 1 0.0006
277 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
278 PRODUCT LABEL ISSUE 4 0.0006
279 MEDICAL DEVICE REMOVAL 1 0.0006
280 SENSITIVITY OF TEETH 1 0.0006
281 GENERALISED OEDEMA 7 0.0006
282 MITRAL VALVE DISEASE 1 0.0006
283 FEAR OF DISEASE 1 0.0006
284 TRANSPLANT DYSFUNCTION 1 0.0006
285 CARDIAC ABLATION 1 0.0006
286 OPHTHALMIC HERPES ZOSTER 1 0.0006
287 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
288 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
289 METAMORPHOPSIA 1 0.0005
290 BLINDNESS TRANSIENT 4 0.0005
291 LYMPH NODE PAIN 1 0.0005
292 BLOOD CHOLESTEROL DECREASED 1 0.0005
293 GINGIVAL RECESSION 1 0.0005
294 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
295 HYPOGEUSIA 1 0.0005
296 COLOSTOMY 1 0.0005
297 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
298 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
299 PRODUCT ADMINISTRATION ERROR 10 0.0005
300 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
301 PRE-EXISTING CONDITION IMPROVED 3 0.0005
302 EAR SWELLING 1 0.0005
303 INFUSION SITE BRUISING 1 0.0005
304 RETROPERITONEAL HAEMATOMA 1 0.0005
305 PRODUCT LOT NUMBER ISSUE 1 0.0005
306 FACIAL PAIN 4 0.0004
307 BRAIN OPERATION 1 0.0004
308 REACTION TO EXCIPIENT 1 0.0004
309 MENOPAUSAL SYMPTOMS 1 0.0004
310 SINUS PAIN 1 0.0004
311 ORAL SURGERY 1 0.0004
312 MACULAR DEGENERATION 5 0.0004
313 VISUAL IMPAIRMENT 51 0.0004
314 DERMAL CYST 1 0.0004
315 VITREOUS FLOATERS 4 0.0004
316 INFREQUENT BOWEL MOVEMENTS 1 0.0004
317 ANGLE CLOSURE GLAUCOMA 1 0.0004
318 MEAN CELL VOLUME INCREASED 1 0.0004
319 PRODUCT USE COMPLAINT 6 0.0004
320 EXFOLIATIVE RASH 1 0.0004
321 BLOOD POTASSIUM ABNORMAL 1 0.0004
322 PRODUCT RESIDUE PRESENT 2 0.0004
323 MIGRAINE WITH AURA 1 0.0004
324 SKIN WRINKLING 1 0.0004
325 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
326 TRICHORRHEXIS 1 0.0004
327 MACULAR OEDEMA 2 0.0004
328 IMPAIRED DRIVING ABILITY 4 0.0004
329 OESOPHAGEAL STENOSIS 1 0.0004
330 RETINAL VEIN OCCLUSION 1 0.0003
331 BLOOD MAGNESIUM DECREASED 3 0.0003
332 IMMUNOSUPPRESSION 3 0.0003
333 THORACIC VERTEBRAL FRACTURE 1 0.0003
334 PRODUCT DOSE OMISSION ISSUE 98 0.0003
335 PRODUCT DISTRIBUTION ISSUE 3 0.0003
336 BLOOD CREATININE DECREASED 1 0.0003
337 DERMATITIS ALLERGIC 4 0.0003
338 BLEPHAROSPASM 2 0.0003
339 INFUSION SITE PRURITUS 1 0.0003
340 PRODUCT PACKAGING ISSUE 3 0.0003
341 SNEEZING 7 0.0003
342 HAEMOGLOBIN ABNORMAL 2 0.0003
343 LYMPHOCYTE COUNT INCREASED 1 0.0003
344 DEAFNESS NEUROSENSORY 1 0.0003
345 INFUSION SITE HAEMORRHAGE 1 0.0003
346 PROSTATE CANCER METASTATIC 1 0.0003
347 WRONG PRODUCT ADMINISTERED 2 0.0003
348 DIABETIC RETINOPATHY 1 0.0003
349 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
350 EUPHORIC MOOD 3 0.0003
351 REGURGITATION 1 0.0003
352 RESPIRATION ABNORMAL 2 0.0003
353 BLOOD CREATININE ABNORMAL 1 0.0003
354 EAR PRURITUS 1 0.0003
355 MACULOPATHY 1 0.0003
356 BODY HEIGHT DECREASED 3 0.0003
357 ACCIDENTAL OVERDOSE 10 0.0003
358 PARADOXICAL DRUG REACTION 1 0.0003
359 SENSITIVE SKIN 2 0.0003
360 CARDIAC DYSFUNCTION 1 0.0003
361 THROAT CLEARING 1 0.0003
362 REBOUND EFFECT 3 0.0003
363 FACE INJURY 1 0.0003
364 INSURANCE ISSUE 4 0.0003
365 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
366 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
367 RHINOVIRUS INFECTION 1 0.0003
368 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
369 SPINAL FUSION SURGERY 1 0.0002
370 RECURRENT CANCER 1 0.0002
371 SMALL INTESTINAL OBSTRUCTION 3 0.0002
372 SELF-MEDICATION 1 0.0002
373 EYE DISORDER 8 0.0002
374 PRODUCT STORAGE ERROR 21 0.0002
375 ONYCHOMADESIS 1 0.0002
376 SLEEP TERROR 1 0.0002
377 MUSCLE FATIGUE 1 0.0002
378 PURULENT DISCHARGE 1 0.0002
379 PRODUCT DISPENSING ISSUE 1 0.0002
380 EXPOSURE VIA SKIN CONTACT 6 0.0002
381 PRODUCT PRESCRIBING ISSUE 5 0.0002
382 IMMOBILE 1 0.0002
383 BEDRIDDEN 3 0.0002
384 PHYSICAL DISABILITY 1 0.0002
385 DRUG EFFECT DELAYED 1 0.0002
386 INJECTION SITE PAPULE 1 0.0002
387 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
388 ARTHRITIS INFECTIVE 1 0.0002
389 PERFORMANCE STATUS DECREASED 1 0.0002
390 NEPHROPATHY 2 0.0002
391 UMBILICAL HERNIA 1 0.0002
392 ARTERIOSCLEROSIS 2 0.0002
393 SKIN ABRASION 1 0.0002
394 THERAPY INTERRUPTED 15 0.0002
395 LIMB OPERATION 1 0.0002
396 PRESCRIBED OVERDOSE 4 0.0002
397 VITAMIN D DEFICIENCY 2 0.0002
398 HOSPICE CARE 2 0.0002
399 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
400 INFLAMMATORY MARKER INCREASED 1 0.0002
401 INABILITY TO AFFORD MEDICATION 2 0.0002
402 SLUGGISHNESS 2 0.0002
403 PERIPHERAL VASCULAR DISORDER 1 0.0002
404 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
405 VARICOSE VEIN 1 0.0002
406 PERIORBITAL OEDEMA 1 0.0002
407 VENTRICULAR EXTRASYSTOLES 2 0.0002
408 DIPLOPIA 5 0.0002
409 ACUTE MYELOID LEUKAEMIA 3 0.0002
410 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
411 DISEASE RECURRENCE 9 0.0002
412 INJECTION SITE DISCHARGE 1 0.0002
413 CHEILITIS 1 0.0002
414 HIP SURGERY 1 0.0002
415 SKIN LACERATION 2 0.0002
416 HYDROCEPHALUS 1 0.0002
417 CHOKING SENSATION 1 0.0002
418 PROSTATIC DISORDER 1 0.0002
419 GASTRIC ULCER HAEMORRHAGE 1 0.0002
420 OFF LABEL USE 158 0.0002
421 HEART RATE ABNORMAL 1 0.0002
422 PRODUCT LEAKAGE 1 0.0002
423 CHOLECYSTITIS ACUTE 1 0.0002
424 DERMATITIS CONTACT 2 0.0002
425 MADAROSIS 2 0.0002
426 METABOLIC DISORDER 1 0.0002
427 PRODUCT LABEL CONFUSION 1 0.0002
428 DEVICE USE ISSUE 3 0.0002
429 HYPOVOLAEMIA 1 0.0002
430 ENERGY INCREASED 1 0.0002
431 CATARACT OPERATION 1 0.0002
432 SINUS HEADACHE 1 0.0002
433 ODYNOPHAGIA 1 0.0002
434 ENDOPHTHALMITIS 1 0.0002
435 PLATELET COUNT ABNORMAL 1 0.0002
436 NOCTURIA 2 0.0002
437 INGUINAL HERNIA 1 0.0002
438 PLEURAL EFFUSION 10 0.0002
439 SPINAL OPERATION 2 0.0002
440 PIGMENTATION DISORDER 1 0.0002
441 PHOTOPSIA 1 0.0002
442 GASTRIC ULCER 3 0.0002
443 THERAPEUTIC RESPONSE CHANGED 1 0.0002
444 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
445 EAR PAIN 3 0.0002
446 RESPIRATORY TRACT INFECTION 4 0.0002
447 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 31 0.0002
448 SOMNAMBULISM 1 0.0002
449 CATARACT 9 0.0002
450 EXPIRED PRODUCT ADMINISTERED 5 0.0002
451 PRESCRIBED UNDERDOSE 3 0.0002
452 SKIN MASS 1 0.0001
453 COLITIS ISCHAEMIC 1 0.0001
454 BLINDNESS 6 0.0001
455 IMPAIRED GASTRIC EMPTYING 2 0.0001
456 PERIPHERAL COLDNESS 2 0.0001
457 DROOLING 1 0.0001
458 SEASONAL ALLERGY 2 0.0001
459 HAND FRACTURE 1 0.0001
460 THERMAL BURN 1 0.0001
461 RETINAL HAEMORRHAGE 1 0.0001
462 PRODUCT SUPPLY ISSUE 1 0.0001
463 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
464 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
465 INTENTIONAL UNDERDOSE 1 0.0001
466 UTERINE LEIOMYOMA 1 0.0001
467 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
468 CEREBRAL DISORDER 1 0.0001
469 HYPERSENSITIVITY 25 0.0001
470 FEELING DRUNK 1 0.0001
471 DRUG INTOLERANCE 13 0.0001
472 PAROSMIA 1 0.0001
473 PRODUCT AVAILABILITY ISSUE 3 0.0001
474 AORTIC ANEURYSM 1 0.0001
475 BOWEL MOVEMENT IRREGULARITY 1 0.0001
476 CONCUSSION 1 0.0001
477 OEDEMA 7 0.0001
478 APHTHOUS ULCER 1 0.0001
479 BRAIN FOG 2 0.0001
480 MULTIPLE ALLERGIES 1 0.0001
481 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
482 NASAL DISCOMFORT 1 0.0001
483 UTERINE CANCER 1 0.0001
484 BLOOD PRESSURE INCREASED 19 0.0001
485 SENSORY LOSS 1 0.0001
486 BLOOD POTASSIUM INCREASED 2 0.0001
487 SWELLING FACE 8 0.0001
488 ABNORMAL FAECES 1 0.0001
489 PHOTOSENSITIVITY REACTION 2 0.0001
490 EOSINOPHIL COUNT INCREASED 1 0.0001
491 LIVE BIRTH 1 0.0001
492 ATRIAL SEPTAL DEFECT 1 0.0001
493 INFUSION SITE ERYTHEMA 1 0.0001
494 PRODUCT COMPLAINT 3 0.0001
495 VITAMIN D DECREASED 1 0.0001
496 SKIN HYPERPIGMENTATION 1 0.0001
497 DEVICE DEFECTIVE 2 0.0001
498 GASTRITIS 3 0.0001
499 PRODUCT COMMUNICATION ISSUE 1 0.0001
500 GALLBLADDER DISORDER 2 0.0001
501 ANAL INCONTINENCE 1 0.0001
502 GASTROINTESTINAL CARCINOMA 1 0.0001
503 LIP DRY 1 0.0001
504 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
505 PNEUMONIA BACTERIAL 1 0.0001
506 RETINAL DETACHMENT 1 0.0001
507 INCREASED TENDENCY TO BRUISE 1 0.0001
508 HEPATIC ENCEPHALOPATHY 1 0.0001
509 BLOOD SODIUM DECREASED 2 0.0001
510 PAIN IN JAW 3 0.0001
511 BLOOD URINE PRESENT 2 0.0001
512 INTENTIONAL DOSE OMISSION 3 0.0001
513 RECALLED PRODUCT ADMINISTERED 1 0.0001
514 LETHARGY 6 0.0001
515 PRODUCT SUBSTITUTION ISSUE 6 0.0001
516 POST PROCEDURAL COMPLICATION 2 0.0001
517 ATELECTASIS 1 0.0001
518 HERNIA 2 0.0001
519 DIZZINESS POSTURAL 1 0.0001
520 AUTOIMMUNE DISORDER 1 0.0001
521 KIDNEY INFECTION 2 0.0001
522 THERAPY CHANGE 1 0.0001
523 SINUS DISORDER 2 0.0001
524 EMPHYSEMA 1 0.0001
525 EXTRA DOSE ADMINISTERED 4 0.0001
526 DISCOMFORT 6 0.0001
527 BODY TEMPERATURE INCREASED 2 0.0001
528 INITIAL INSOMNIA 1 0.0001
529 EAR DISCOMFORT 1 0.0001
530 THERAPY CESSATION 5 0.0001
531 INJECTION SITE WARMTH 2 0.0001
532 LIMB DISCOMFORT 3 0.0001
533 COVID-19 17 0.0001
534 POOR VENOUS ACCESS 1 0.0001
535 TENDERNESS 1 0.0001
536 PRODUCT ODOUR ABNORMAL 1 0.0001
537 DERMATITIS 2 0.0001
538 TRANSFUSION 1 0.0001
539 FULL BLOOD COUNT ABNORMAL 1 0.0001
540 POOR QUALITY SLEEP 2 0.0001
541 SKIN CANCER 2 0.0001
542 HALLUCINATION 7 0.0001
543 BACK INJURY 1 0.0001
544 INTENTIONAL PRODUCT MISUSE 8 0.0001
545 BLOOD GLUCOSE FLUCTUATION 1 0.0001
546 HEADACHE 57 0.0001
547 GASTROINTESTINAL PAIN 1 0.0001
548 BLOOD PRESSURE DECREASED 6 0.0001
549 FOOT DEFORMITY 1 0.0001
550 NERVE INJURY 1 0.0001
551 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
552 THERAPY NON-RESPONDER 4 0.0001
553 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
554 FLATULENCE 5 0.0001
555 SCAB 1 0.0001
556 INTERNAL HAEMORRHAGE 1 0.0001
557 TINNITUS 4 0.0001
558 DRY MOUTH 7 0.0001
559 VASCULITIS 1 0.0001
560 BLOOD CHOLESTEROL INCREASED 4 0.0001
561 DYSPHONIA 5 0.0001
562 COVID-19 PNEUMONIA 1 0.0001
563 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
564 CYTOPENIA 1 0.0001
565 MUSCLE ATROPHY 1 0.0001
566 HAEMATEMESIS 2 0.0001
567 FLUID RETENTION 4 0.0001
568 INJECTION SITE IRRITATION 1 0.0001
569 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
570 GASTROINTESTINAL DISORDER 7 0.0001
571 MYDRIASIS 1 0.0001
572 ADVERSE DRUG REACTION 7 0.0001
573 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
574 SKIN ULCER 2 0.0001
575 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
576 PARAESTHESIA 12 0.0001
577 IMMUNE SYSTEM DISORDER 1 0.0001
578 TOOTH INFECTION 1 0.0001
579 SARS-COV-2 TEST POSITIVE 1 0.0001
580 ADVERSE REACTION 1 0.0001
581 CARDIAC FAILURE CONGESTIVE 6 0.0001
582 SINUS CONGESTION 1 0.0001
583 DYSKINESIA 3 0.0001
584 LIMB INJURY 2 0.0001
585 TACHYPNOEA 1 0.0001
586 GINGIVAL BLEEDING 1 0.0001
587 TREATMENT NONCOMPLIANCE 4 0.0001
588 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
589 CORONARY ARTERY OCCLUSION 1 0.0001
590 MENTAL STATUS CHANGES 2 0.0001
591 HUNGER 1 0.0001
592 DEMENTIA 2 0.0001
593 BLISTER 4 0.0001
594 DEVICE OCCLUSION 1 0.0001
595 SLEEP DISORDER 5 0.0001
596 HEART RATE INCREASED 7 0.0001
597 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
598 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
599 BRONCHOSPASM 1 0.0001
600 RED BLOOD CELL COUNT DECREASED 2 0.0001
601 HYPERSOMNIA 2 0.0001
602 MYELODYSPLASTIC SYNDROME 1 0.0001
603 ANOSMIA 1 0.0001
604 HYPOKINESIA 1 0.0001
605 APATHY 1 0.0001
606 PALPITATIONS 8 0.0001
607 NASAL CONGESTION 4 0.0001
608 LABORATORY TEST ABNORMAL 2 0.0001
609 DISEASE PROGRESSION 8 0.0001
610 INSOMNIA 18 0.0001
611 BRONCHITIS 5 0.0001
612 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
613 THROAT IRRITATION 3 0.0001
614 BLOOD COUNT ABNORMAL 1 0.0001
615 ABDOMINAL DISCOMFORT 11 0.0001
616 NASOPHARYNGITIS 12 0.0001
617 DEATH 56 0.0001
618 THYROID DISORDER 1 0.0001
619 LYMPHOMA 1 0.0001
620 ANKLE FRACTURE 1 0.0001
621 URINARY TRACT INFECTION 11 0.0001
622 DELUSION 1 0.0001
623 EJECTION FRACTION DECREASED 1 0.0001
624 RESPIRATORY TRACT CONGESTION 1 0.0001
625 ULCER 1 0.0001
626 MIGRAINE 6 0.0001
627 ABSCESS 1 0.0001
628 HYPOTHYROIDISM 2 0.0001
629 BLOOD GLUCOSE DECREASED 3 0.0001
630 DIZZINESS 31 0.0001
631 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
632 IMPAIRED HEALING 2 0.0001
633 FATIGUE 47 0.0001
634 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
635 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
636 DRUG INEFFECTIVE 79 0.0001
637 BLOOD UREA INCREASED 1 0.0001
638 CELLULITIS 3 0.0001
639 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
640 SINUSITIS 6 0.0001
641 HAEMOGLOBIN DECREASED 6 0.0001
642 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
643 INFLAMMATION 3 0.0001
644 PARANOIA 1 0.0001
645 ABDOMINAL DISTENSION 6 0.0001
646 OEDEMA PERIPHERAL 7 0.0001
647 ORTHOSTATIC HYPOTENSION 1 0.0001
648 SYRINGE ISSUE 1 0.0001
649 HEART RATE DECREASED 2 0.0001
650 DERMATITIS ATOPIC 3 0.0001
651 HYPOXIA 2 0.0001
652 LYMPHOCYTE COUNT DECREASED 1 0.0001
653 HEAD DISCOMFORT 1 0.0001
654 ISCHAEMIC STROKE 1 0.0001
655 THIRST 1 0.0001
656 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
657 BONE DISORDER 1 0.0001
658 PANIC ATTACK 2 0.0001
659 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
660 FEELING ABNORMAL 13 0.0001
661 OROPHARYNGEAL PAIN 5 0.0001
662 CHEST PAIN 10 0.0001
663 DYSGEUSIA 4 0.0001
664 BACTERIAL INFECTION 1 0.0001
665 MIDDLE INSOMNIA 1 0.0001
666 ERYTHEMA 11 0.0001
667 COUGH 15 0.0001
668 EPISTAXIS 4 0.0001
669 CARDIAC DISORDER 5 0.0001
670 DYSPNOEA EXERTIONAL 2 0.0001
671 HOT FLUSH 4 0.0001
672 INTESTINAL OBSTRUCTION 2 0.0001
673 FEELING JITTERY 1 0.0001
674 INCREASED APPETITE 1 0.0001
675 LOWER LIMB FRACTURE 1 0.0001
676 ACUTE RESPIRATORY FAILURE 1 0.0001
677 DECREASED APPETITE 12 0.0001
678 PRODUCT QUALITY ISSUE 7 0.0001
679 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
680 ORAL HERPES 1 0.0001
681 BONE PAIN 3 0.0001
682 SURGERY 3 0.0001
683 MEMORY IMPAIRMENT 7 0.0001
684 ALOPECIA 10 0.0001
685 DYSPEPSIA 5 0.0001
686 HAEMATOCRIT DECREASED 1 0.0001
687 BLOOD PRESSURE ABNORMAL 1 0.0001
688 UPPER LIMB FRACTURE 1 0.0001
689 SPINAL FRACTURE 1 0.0000
690 CYTOKINE RELEASE SYNDROME 1 0.0000
691 FULL BLOOD COUNT DECREASED 1 0.0000
692 CONDITION AGGRAVATED 15 0.0000
693 TASTE DISORDER 1 0.0000
694 PSORIATIC ARTHROPATHY 2 0.0000
695 VERTIGO 3 0.0000
696 RIB FRACTURE 1 0.0000
697 PRODUCT USE IN UNAPPROVED INDICATION 12 0.0000
698 DEPRESSION 11 0.0000
699 RASH 21 0.0000
700 FALL 16 0.0000
701 MOUTH ULCERATION 1 0.0000
702 SKIN EXFOLIATION 4 0.0000
703 HALLUCINATION, VISUAL 1 0.0000
704 HYPERTENSION 10 0.0000
705 RETCHING 1 0.0000
706 IMPAIRED WORK ABILITY 1 0.0000
707 NAUSEA 37 0.0000
708 LIVER FUNCTION TEST INCREASED 1 0.0000
709 HYPOACUSIS 2 0.0000
710 RHINORRHOEA 3 0.0000
711 DEEP VEIN THROMBOSIS 3 0.0000
712 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
713 PRODUCT DOSE OMISSION 3 0.0000
714 TACHYCARDIA 4 0.0000
715 STEVENS-JOHNSON SYNDROME 1 0.0000
716 INFLUENZA 5 0.0000
717 SOMNOLENCE 9 0.0000
718 PULMONARY OEDEMA 2 0.0000
719 CHROMATURIA 1 0.0000
720 HEART RATE IRREGULAR 1 0.0000
721 PRURITUS 17 0.0000
722 NO ADVERSE EVENT 8 0.0000
723 INCORRECT DOSE ADMINISTERED 10 0.0000
724 SKIN IRRITATION 2 0.0000
725 SHOCK 1 0.0000
726 SEIZURE 5 0.0000
727 BACK PAIN 10 0.0000
728 RENAL DISORDER 2 0.0000
729 BURNING SENSATION 3 0.0000
730 MOBILITY DECREASED 3 0.0000
731 LOCALISED INFECTION 1 0.0000
732 CEREBROVASCULAR ACCIDENT 7 0.0000
733 CONSTIPATION 9 0.0000
734 UNDERDOSE 3 0.0000
735 ATRIAL FIBRILLATION 4 0.0000
736 LUNG DISORDER 2 0.0000
737 PAIN IN EXTREMITY 12 0.0000
738 DYSPNOEA 23 0.0000
739 AGEUSIA 1 0.0000
740 WEIGHT DECREASED 11 0.0000
741 DIABETES MELLITUS 3 0.0000
742 UNRESPONSIVE TO STIMULI 1 0.0000
743 HAEMATOMA 1 0.0000
744 SPEECH DISORDER 2 0.0000
745 APPLICATION SITE ERYTHEMA 1 0.0000
746 ANHEDONIA 1 0.0000
747 PANCREATITIS 2 0.0000
748 DEPRESSED MOOD 2 0.0000
749 BRADYCARDIA 2 0.0000
750 EAR INFECTION 1 0.0000
751 PLATELET COUNT DECREASED 4 0.0000
752 PRODUCT USE ISSUE 7 0.0000
753 DISTURBANCE IN ATTENTION 2 0.0000
754 FREQUENT BOWEL MOVEMENTS 1 0.0000
755 GAIT DISTURBANCE 7 0.0000
756 INFLUENZA LIKE ILLNESS 3 0.0000
757 PROCEDURAL PAIN 1 0.0000
758 HAEMOPTYSIS 1 0.0000
759 URTICARIA 6 0.0000
760 NECK PAIN 2 0.0000
761 RHEUMATOID ARTHRITIS 4 0.0000
762 ANXIETY 10 0.0000
763 HERPES ZOSTER 2 0.0000
764 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
765 BALANCE DISORDER 3 0.0000
766 INFECTION 5 0.0000
767 DYSSTASIA 1 0.0000
768 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
769 WHEEZING 2 0.0000
770 ARTHRALGIA 14 0.0000
771 RENAL INJURY 1 0.0000
772 RESPIRATORY DISORDER 1 0.0000
773 IRRITABILITY 2 0.0000
774 BLOOD POTASSIUM DECREASED 1 0.0000
775 CORONARY ARTERY DISEASE 1 0.0000
776 THERAPEUTIC RESPONSE DECREASED 2 0.0000
777 EPILEPSY 1 0.0000
778 MUSCLE SPASMS 6 0.0000
779 ADVERSE EVENT 3 0.0000
780 DYSPHAGIA 3 0.0000
781 HEAD INJURY 1 0.0000
782 NEUROPATHY PERIPHERAL 3 0.0000
783 CYSTITIS 1 0.0000
784 MOOD SWINGS 1 0.0000
785 MOVEMENT DISORDER 1 0.0000
786 DIARRHOEA 20 0.0000
787 LACTIC ACIDOSIS 1 0.0000
788 CHOLELITHIASIS 1 0.0000
789 STAPHYLOCOCCAL INFECTION 1 0.0000
790 INFUSION RELATED REACTION 2 0.0000
791 VIRAL INFECTION 1 0.0000
792 FUNGAL INFECTION 1 0.0000
793 URINARY RETENTION 1 0.0000
794 NEOPLASM MALIGNANT 2 0.0000
795 GAIT INABILITY 1 0.0000
796 HYPOTENSION 6 0.0000
797 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
798 CHEST DISCOMFORT 3 0.0000
799 ILLNESS 3 0.0000
800 NEOPLASM PROGRESSION 1 0.0000
801 RASH MACULAR 1 0.0000
802 HYPERKALAEMIA 1 0.0000
803 LYMPHADENOPATHY 1 0.0000
804 CRYING 1 0.0000
805 AGITATION 2 0.0000
806 DYSURIA 1 0.0000
807 SEPSIS 3 0.0000
808 HYPOAESTHESIA 4 0.0000
809 ASTHENIA 10 0.0000
810 BLOOD GLUCOSE INCREASED 5 0.0000
811 UNEVALUABLE EVENT 2 0.0000
812 ACNE 2 0.0000
813 CHRONIC KIDNEY DISEASE 2 0.0000
814 PERIPHERAL SWELLING 4 0.0000
815 ABDOMINAL PAIN 6 0.0000
816 PLASMA CELL MYELOMA 1 0.0000
817 CHILLS 3 0.0000
818 DRUG DOSE OMISSION BY DEVICE 2 0.0000
819 ABNORMAL BEHAVIOUR 1 0.0000
820 DISORIENTATION 1 0.0000
821 THROMBOSIS 2 0.0000
822 CONFUSIONAL STATE 4 0.0000
823 ABDOMINAL PAIN UPPER 5 0.0000
824 TREATMENT FAILURE 2 0.0000
825 POLLAKIURIA 1 0.0000
826 ROAD TRAFFIC ACCIDENT 1 0.0000
827 OSTEOARTHRITIS 1 0.0000
828 MYALGIA 4 0.0000
829 VAGINAL HAEMORRHAGE 1 0.0000
830 MENTAL DISORDER 1 0.0000
831 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
832 INJECTION SITE PAIN 7 0.0000
833 MALAISE 10 0.0000
834 PAIN 14 0.0000
835 RENAL FAILURE 3 0.0000
836 LIVER DISORDER 1 0.0000
837 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
838 NEPHROLITHIASIS 1 0.0000
839 SKIN DISCOLOURATION 1 0.0000
840 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
841 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
842 VOMITING 10 0.0000
843 ARRHYTHMIA 1 0.0000
844 PRODUCTIVE COUGH 1 0.0000
845 CONTUSION 2 0.0000
846 HYPOGLYCAEMIA 1 0.0000
847 SYNCOPE 2 0.0000
848 FLUSHING 2 0.0000
849 HAEMORRHAGE 2 0.0000
850 MUSCULOSKELETAL PAIN 1 0.0000
851 DRUG INTERACTION 3 0.0000
852 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
853 PNEUMONIA 6 0.0000
854 HAEMATOCHEZIA 1 0.0000
855 ANAPHYLACTIC REACTION 1 0.0000
856 TREMOR 3 0.0000
857 ARTHROPATHY 1 0.0000
858 MEDICATION ERROR 1 0.0000
859 WEIGHT INCREASED 4 0.0000
860 MUSCULAR WEAKNESS 2 0.0000
861 BLADDER CANCER 1 0.0000
862 JOINT SWELLING 2 0.0000
863 SUICIDE ATTEMPT 1 0.0000
864 ILL-DEFINED DISORDER 1 0.0000
865 INJECTION SITE ERYTHEMA 2 0.0000
866 EXPOSURE DURING PREGNANCY 1 0.0000
867 ANAEMIA 3 0.0000
868 LOSS OF CONSCIOUSNESS 2 0.0000
869 INTENTIONAL OVERDOSE 1 0.0000
870 AMNESIA 1 0.0000
871 BLOOD CREATININE INCREASED 1 0.0000
872 PSORIASIS 2 0.0000
873 INJECTION SITE PRURITUS 1 0.0000
874 HEPATIC ENZYME INCREASED 1 0.0000
875 INJURY 1 0.0000
876 OVERDOSE 3 0.0000
877 ACUTE KIDNEY INJURY 2 0.0000
878 INJECTION SITE SWELLING 1 0.0000
879 HOSPITALISATION 2 0.0000
880 ARTHRITIS 1 0.0000
881 INJECTION SITE BRUISING 1 0.0000
882 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
883 PYREXIA 4 0.0000
884 MYOCARDIAL INFARCTION 2 0.0000
885 MUSCULOSKELETAL STIFFNESS 1 0.0000
886 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
887 DEVICE ISSUE 1 0.0000
888 SUICIDAL IDEATION 1 0.0000
889 SWELLING 1 0.0000
890 PULMONARY EMBOLISM 1 0.0000
891 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
892 ASTHMA 1 0.0000
893 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
894 EMOTIONAL DISTRESS 1 0.0000
895 HYPERHIDROSIS 1 0.0000
896 DEHYDRATION 1 0.0000
897 DRY SKIN 1 0.0000
898 DRUG DOSE OMISSION 1 0.0000